- Home
- ADD vs GBIO Comparison
ADD vs GBIO Comparison
Compare ADD & GBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADD
- GBIO
- Stock Information
- Founded
- ADD 2002
- GBIO 2016
- Country
- ADD United States
- GBIO United States
- Employees
- ADD N/A
- GBIO N/A
- Industry
- ADD Engineering & Construction
- GBIO Biotechnology: Pharmaceutical Preparations
- Sector
- ADD Consumer Discretionary
- GBIO Health Care
- Exchange
- ADD Nasdaq
- GBIO Nasdaq
- Market Cap
- ADD 25.4M
- GBIO 29.2M
- IPO Year
- ADD N/A
- GBIO 2020
- Fundamental
- Price
- ADD $1.03
- GBIO $0.39
- Analyst Decision
- ADD
- GBIO Strong Buy
- Analyst Count
- ADD 0
- GBIO 4
- Target Price
- ADD N/A
- GBIO $7.33
- AVG Volume (30 Days)
- ADD 451.7K
- GBIO 1.1M
- Earning Date
- ADD 06-25-2025
- GBIO 08-06-2025
- Dividend Yield
- ADD N/A
- GBIO N/A
- EPS Growth
- ADD N/A
- GBIO N/A
- EPS
- ADD N/A
- GBIO N/A
- Revenue
- ADD $1,770,000.00
- GBIO $24,556,000.00
- Revenue This Year
- ADD N/A
- GBIO N/A
- Revenue Next Year
- ADD N/A
- GBIO N/A
- P/E Ratio
- ADD N/A
- GBIO N/A
- Revenue Growth
- ADD 66.91
- GBIO 146.47
- 52 Week Low
- ADD $0.56
- GBIO $0.30
- 52 Week High
- ADD $185.00
- GBIO $3.65
- Technical
- Relative Strength Index (RSI)
- ADD 54.85
- GBIO 52.02
- Support Level
- ADD $0.87
- GBIO $0.32
- Resistance Level
- ADD $1.03
- GBIO $0.36
- Average True Range (ATR)
- ADD 0.09
- GBIO 0.03
- MACD
- ADD 0.01
- GBIO 0.00
- Stochastic Oscillator
- ADD 74.10
- GBIO 81.00
About ADD Color Star Technology Co. Ltd.
Color Star Technology Co Ltd is an entertainment technology company with a network that focuses on the application of technology and artificial intelligence in the entertainment industry. It provides online entertainment performances and online education through its wholly-owned subsidiaries Color Metaverse and CACM. The curriculum developed by the company includes music, sports, animation, painting and calligraphy, film and television, and life skills, covering various aspects of entertainment, sports, and culture.
About GBIO Generation Bio Co.
Generation Bio Co is a genetics medicine company focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable highly differentiated therapeutic applications. Its first platform is a potent, highly selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for highly selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.